Tocainide-associated interstitial pneumonitis.
D000813:Anilides / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D004417:Dyspnea / Q000139:chemically induced; D006801:Humans; D000860:Hypoxia / Q000139:chemically induced; D009203:Myocardial Infarction / Q000188:drug therapy; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D016677:Tocainide
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D016677:Tocainide